Search by Drug Name or NDC
NDC 16729-0484-03 ATROPINE SULFATE 0.1 mg/mL Details
ATROPINE SULFATE 0.1 mg/mL
ATROPINE SULFATE is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Accord Healthcare, Inc.,. The primary component is ATROPINE SULFATE.
Product Information
| NDC | 16729-0484 |
|---|---|
| Product ID | 16729-484_0c604d5f-3209-7c5b-e063-6294a90a6072 |
| Associated GPIs | 4910101010E510 4910101010E505 |
| GCN Sequence Number | 004817 |
| GCN Sequence Number Description | atropine sulfate SYRINGE 0.1 MG/ML INJECTION |
| HIC3 | J2A |
| HIC3 Description | BELLADONNA ALKALOIDS |
| GCN | 18661 |
| HICL Sequence Number | 002004 |
| HICL Sequence Number Description | ATROPINE SULFATE |
| Brand/Generic | Generic |
| Proprietary Name | ATROPINE SULFATE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ATROPINE SULFATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 0.1 |
| Active Ingredient Units | mg/mL |
| Substance Name | ATROPINE SULFATE |
| Labeler Name | Accord Healthcare, Inc., |
| Pharmaceutical Class | Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA212868 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 16729-0484-03 (16729048403)
| NDC Package Code | 16729-484-03 |
|---|---|
| Billing NDC | 16729048403 |
| Package | 10 mL in 1 SYRINGE, GLASS (16729-484-03) |
| Marketing Start Date | 2021-07-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |